1. 223 IMPROVEMENTS IN CAROTID ARTERY INTIMA-MEDIA THICKNESS IN TYPE 2 DIABETIC PATIENTS USING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ LIGAND, ROSIGLITAZONE. (10th December 2015) Authors: Kronstad, D.; Cole, C.; Aguinaldo, M.; Lyko, A.; Chao, E.; Daud, S.; Krishnamoorthy, S.; Vu, K.; Magbual, R.; Liu, W.; Lee, S. Journal: Journal of investigative medicine Issue: Volume 53:Number 1(2005) Page Start: S117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 85 TARGETING THE DYSMETABOLIC SYNDROME IN A CARDIOVASCULAR DISEASE DIABETIC COHORT WITH ROSIGLITAZONE: 1 YEAR ANALYSIS. (1st January 2005) Authors: Aguinaldo, M.; Kronstad, D.; Cole, C.; Lyko, A.; Chao, E.; Daud, S.; Krishnamoorthy, S.; Vu, K.; Liu, W.; Magbual, R.; Petrofsky, J.; Lee, S. Journal: Journal of investigative medicine Issue: Volume 53:Number 1(2005) Page Start: S92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗